Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04419168 · ClinicalTrials.gov registry record · NA

Cognitive Behavioral Therapy and Real-Time Pain Management Intervention for Sickle Cell Via Mobile Applications

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
359
Enrollment target

NCT04419168 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 359 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04419168, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
359 participants
Enrollment target

Study Summary

The investigators are conducting a comparative effectiveness trial among adult patients with sickle cell disease (SCD) who report chronic pain (N = 350), randomized to receive either mobile phone-delivered computerized cognitive behavioral therapy (cCBT; n = 175) or digital education (m-Education; n = 175). Both intervention groups will receive weekly (more frequent if requested or needed) follow-up with a health coach for at least 3 months to reinforce learned materials. Both groups will also use their mobile device to track daily pain, mood, and medication used for two-week periods at baseline and each of the follow-up points (3, 6 and 12 months). Participants will also be given access to a study-associated online support group page where members can discuss with other patients, issues participants faced and what skills were or could be used to address them. Participants will continue all routine care including opioid pain management and novel therapies.

Interventions

  • OTHER cCBT
  • OTHER m-Education

Trial Details

FieldValue
Enrollment Target 359 participants
Start Date 2020-08-12
Est. Completion 2023-12-11
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT04419168

The ClinicalTrials.gov registry entry for NCT04419168 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 359 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which cCBT is the first listed.

NCT04419168 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04419168 about?

NCT04419168 is a clinical study titled "Cognitive Behavioral Therapy and Real-Time Pain Management Intervention for Sickle Cell Via Mobile Applications". The investigators are conducting a comparative effectiveness trial among adult patients with sickle cell disease (SCD) who report chronic pain (N = 350), randomized to receive either mobile phone-delivered computerized cognitive behavioral therapy (cCBT; n = 175) or digital education (m-Education; n...

What is the current status of trial NCT04419168?

This trial is currently completed. It is a NA study. The enrollment target is 359 participants. The study started on 2020-08-12. Estimated completion is 2023-12-11.

What interventions are being tested in trial NCT04419168?

The interventions under investigation include: cCBT (OTHER), m-Education (OTHER).

Who is sponsoring clinical trial NCT04419168?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.